Pfizer Request for Proposals: Independent Medical Education RFP – Diagnosis and Diagnostic Tests for Metallo-β- Lactamase (MBL) Producing Bacterial Infections

The Pfizer Independent Medical Education request for proposal (RFP): Diagnosis and Diagnostic Tests for Metallo-β–Lactamase (MBL) Producing Bacterial Infections is open for applications.

This competitive program aims to foster healthcare professional education to support them in making evidence-informed decisions in the diagnosis and management of patients with Metallo-β-Lactamase (MBL) producing bacterial infections.

Geographic Scope:

  • Global excluding United States and Canada.

Research areas:

  • Potential applicants are encouraged to identify and address the educational needs of healthcare professionals relating to the early diagnosis of MBL-producing bacterial infections to improve the management of patients with these infections. This may include:

    • Needs assessment to better understand, assess and identify knowledge gaps and opportunities for action in diagnosis and testing including understanding of risk factors.

    • Educational tools/resources to reduce information barriers and knowledge acquisition.

    • Educational programs to improve knowledge comprehension and ensure equitable access and improved patient outcomes.

Funding details:

  • Individual projects requesting up to $100,000 USD will be considered.
  • Pfizer anticipates awarding 2 projects.

Read more here.

Application deadline April 18, 2024.

SHARE

Upcoming opportunities